The Rising Issue of Osteoporosis in Young People Mayank, a 17-year-old, was engrossed in his studies for engineering entrance exams. His extended hours of sitting led him to snack on chips and soft ...
Discover how chromium, magnesium, zinc, and other micronutrients influence insulin sensitivity and glucose metabolism—key factors in preventing and managing Type 2 diabetes.
New research from Johns Hopkins Medicine shows that the enzyme biliverdin reductase A (BVRA) plays a direct protective role ...
The activation and deactivation of apoptosis is a promising field of research in basic biomedical research. The team led by Prof. Franz Hagn from the Chair of Structural Membrane Biochemistry at the ...
6don MSN
AI model predicts peptide sequences that prevent ribosome stalling in E. coli protein production
Proteins sourced from microorganisms are attracting attention for their potential in biomanufacturing a variety of products, ...
The open-source AI model improves transparency in predicting how proteins interact with other molecules, which could speed up drug discovery.
If cancer is a disease of overabundance, where cells divide without restraint and tumors grow despite the body's best interests, then degenerative diseases are disorders of deprivation. When ...
Lung06 Phase 3 Trial of ENHERTU Initiated as First-Line Therapy in Patients with HER2 Overexpressing Metastatic NSCLC ...
Background/Aims The neuroprotective effect of nicotinamide (NAM) supplementation has been demonstrated in both animal models ...
Merck and Eisai Announce WELIREG® Plus LENVIMA® Met Primary Endpoint of PFS in Certain Previously Treated Patients With ...
Merck Announces KEYTRUDA Plus WELIREG Met Primary Endpoint of DFS in Certain Patients With Clear Cell Renal Cell Carcinoma ...
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the presentation of multiple abstracts demonstrating the clinical benefits of treatment with CFTR modulators, including the Company’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results